Search

Your search keyword '"Talwar, Suneel"' showing total 190 results

Search Constraints

Start Over You searched for: Author "Talwar, Suneel" Remove constraint Author: "Talwar, Suneel"
190 results on '"Talwar, Suneel"'

Search Results

1. Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment

2. An analysis of long‐term clinical outcome following the use of excimer laser coronary atherectomy in a large UK PCI center

4. Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve–Guided Revascularization Strategy

7. Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes

8. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

9. A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial

12. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography–Stratified Analysis of ORBITA

13. Molecular forms of brain natriuretic peptide and cardiotrophin-1 in the assessment of left ventricular systolic dysfunction after myocardial infarction and in subjects with chronic heart failure

16. Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease: The CvLPRIT Trial

19. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease: Physiology-Stratified Analysis of ORBITA

21. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

22. 1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI Trial

23. 1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI

26. Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

29. Association of sex with outcomes in patients undergoing percutaneous coronary intervention: a subgroup analysis of the global leaders randomized clinical trial

30. Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention

33. Application of the DILEMMA score to improve lesion selection for invasive physiological assessment

34. Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial

35. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography–Stratified Analysis of ORBITA.

36. TCT-664 Twelve-Month Clinical Outcomes Comparing Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Coronary Stents in Patients With De Novo Native Coronary Artery Lesions: The meriT-V Randomized Trial

38. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

39. Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial

40. Two-Year Outcomes of High Bleeding Risk Patients after Polymer-Free Drug-Coated Stents

41. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI

42. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents

43. Emergency ('bailout') balloon aortic valvuloplasty following diagnostic cardiac catheterisation in a patient with severe valvular aortic stenosis and severe coronary artery disease

44. ESTABLISHING INTERVENTIONAL TECHNOLOGIES TO TREAT UNDER EXPANDED STENTS: A ROLE FOR EXCIMER CORONARY LASER ATHERECTOMY.

45. Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve–Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial

47. Reply

49. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vsaspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Catalog

Books, media, physical & digital resources